Hybrid HEOR Associate Director β€” Payer & Outcomes Strategy

Hybrid HEOR Associate Director β€” Payer & Outcomes Strategy

Full-Time 59400 - 72600 Β£ / year (est.) Hybrid
B

At a Glance

  • Tasks: Lead payer evidence strategies and shape patient-relevant outcomes plans.
  • Company: BioMarin Pharmaceutical Inc., a leader in innovative therapies.
  • Benefits: Hybrid work model, competitive salary, and opportunities for professional growth.
  • Other info: Join a dynamic team focused on improving market access for innovative treatments.
  • Why this job: Make a real difference in patient outcomes and collaborate with diverse teams.
  • Qualifications: Deep HEOR expertise and experience with PRO measures and HTA submissions.

The predicted salary is between 59400 - 72600 Β£ per year.

BioMarin Pharmaceutical Inc. in London is seeking an Associate Director, Health Economics and Outcomes Research to lead payer evidence strategies across early-stage assets. You will shape patient-relevant outcomes plans and coordinate with Value & Access, Commercial, Medical Affairs and Clinical Development teams. This hybrid role requires deep HEOR expertise, strong collaboration skills and experience with PRO measures, HTA submissions and global value dossiers to support market access.

Hybrid HEOR Associate Director β€” Payer & Outcomes Strategy employer: BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. is an exceptional employer, offering a dynamic work environment in London that fosters collaboration and innovation. With a strong focus on employee growth, we provide opportunities for professional development and the chance to make a meaningful impact in the field of health economics and outcomes research. Our inclusive culture values diverse perspectives, ensuring that every team member contributes to shaping patient-relevant outcomes and advancing market access strategies.

B

Contact Details:

BioMarin Pharmaceutical Inc. Recruitment Team

We think you need these skills to ace Hybrid HEOR Associate Director β€” Payer & Outcomes Strategy

Health Economics Expertise
Outcomes Research
Payer Evidence Strategies
Patient-Reported Outcomes (PRO) Measures
Health Technology Assessment (HTA) Submissions
Global Value Dossiers
Collaboration Skills